Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fusion Fuel Announces Approximately $1.14 Million in New LPG Engineering Subcontracts Awarded to Al Shola Gas Across Multiple Projects in Dubai, UAE
-
American Rare Earths Awards Whole of Property Development Assessment for Halleck Creek
-
Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Diseas
-
22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative
-
Ahold Delhaize USA Introduces Pay by Bank Partnership with Fiserv to Expand Digital Payment Options for Online Grocery Orders
-
First Onsite launches Life Sciences Division to protect critical environments
-
Virtuix to Present at Exclusive Investor Forum at Mar-a-Lago Club in Palm Beach, Florida
-
Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements
-
Arcadia Expands Leadership Team to Redefine AI-Driven Healthcare Performance and Scale into Life Sciences
-
Tenant Turner Releases AI Virtual Agent Beta to Automate Lead Conversations and Schedule Showings Faster
-
LK Tech Appoints Matthew Marker-Kump as Chief Revenue Officer
-
Galveston Police Department Adopts Non-Lethal Response Solutions with Purchase of BolaWrap® Devices and WrapTactics™ Subscription, Supported by In-Person Training as Part of Broader NLR Strategy
-
CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting
-
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
-
Creative Realities, Inc. Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call Information
-
Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures
-
Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
-
NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia
-
UgoWork brings AI-powered fleet intelligence and MHE performance insights to MODEX 2026
-
Everbright Health Announces AI-Enabled Platform to Unlock Access to Advanced Mental Health Interventions
-
International Association of Fire Chiefs Launches National Volunteer Firefighter Recruitment Campaign
-
Malogica Solutions Lda. and UDMTEK Bring On-Premise PLC Diagnostics to European Manufacturers
-
Akamai Technologies To Hold First Quarter 2026 Investor Conference Call On Thursday, May 7, at 4:30 PM ET
-
Sanford Heisler Sharp McKnight Files Additional Federal Tort Claims Act Complaint Against the Army on Behalf of Victim of Army Doctor Blaine McGraw
-
Ipsos: Disclosure of trading in own shares under a share buyback programme (30 March to 2 April 2026)
-
Bread Financial Schedules First Quarter 2026 Earnings Conference Call for Apr. 23
-
Rover Reveals How Americans Are Redefining Pet Parenthood Across Generations
-
Coeptis Announces Approval of Z Squared Inc.’s Nasdaq Listing Application
-
Sustainable Green Team, Ltd. (SGTM) Discloses 169 Pending Patent Applications Establishing "Physical Truth Infrastructure"
-
Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference
-
Inspiro Announces Strategic Expansion into Comprehensive Business Process Services to Drive Next-Generation Enterprise Efficiency
-
Otis College to Release New Research Examining AI’s Influence on California’s Creative Economy on April 7, 2026, at Snap Inc. Headquarters
-
EssilorLuxottica: Disclosure of transactions in own shares
-
IBA – ACQUISITION OF OWN SHARES
-
Ilkka Oyj: Acquisition of own shares on 7 April 2026
-
Technip Energies awarded a substantial authorization to advance Commonwealth LNG project ahead of Final Investment Decision
-
Planisware - Statement of own shares dealings - 30 March to 3 April 2026
-
Rexel: Disclosure of trading in own shares from March 30 to April 02, 2026
-
Worldline : Monthly information relating to the total number of voting rights and shares making up the share capital on 31 March 2026
-
Cognition Therapeutics to Present at Needham Virtual Healthcare Conference
-
DISCLOSURE FISCAL 2026/22 OF TRANSACTIONS ON TREASURY SHARES
-
Aramis Group - Declaration of transactions on own shares conducted from March 30 to April 3, 2026
-
Total number of shares and voting rights at March 31, 2026
-
Euronext publishes its detailed dividend payment schedule for 2026
-
Coface announces the publication of its 2025 Universal Registration Document
-
Convening of the Annual General Meeting of Euronext N.V.
-
Transgene to Participate in Upcoming Investor Meetings
-
KPN reports on progress of € 250m share buyback
-
Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption
-
Sidetrade Accelerates Toward AI-native with “O2C Intelligence 2030”

